Mirion Technologies (NYSE:MIR) Given New $24.00 Price Target at Citigroup

Mirion Technologies (NYSE:MIR) had its price objective reduced by analysts at Citigroup from $28.00 to $24.00 in a research note issued on Thursday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. Citigroup’s price objective would indicate a potential upside of 61.94% from the stock’s current price.

A number of other analysts have also recently issued reports on MIR. B. Riley Financial decreased their target price on Mirion Technologies from $29.00 to $27.00 and set a “buy” rating for the company in a research report on Thursday. Morgan Stanley lowered their target price on shares of Mirion Technologies from $27.00 to $25.00 and set an “equal weight” rating on the stock in a research report on Monday, July 13th. The Goldman Sachs Group reaffirmed a “buy” rating and issued a $23.00 target price on shares of Mirion Technologies in a report on Wednesday. Finally, Weiss Ratings downgraded shares of Mirion Technologies from a “sell (d+)” rating to a “sell (d)” rating in a research report on Monday, July 20th. One investment analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $26.25.

Mirion Technologies Trading Up 1.7%

NYSE MIR traded up $0.25 on Thursday, reaching $14.82. The stock had a trading volume of 4,439,486 shares, compared to its average volume of 3,712,910. The company has a quick ratio of 2.63, a current ratio of 3.19 and a debt-to-equity ratio of 0.63. The firm has a market capitalization of $3.71 billion, a price-to-earnings ratio of 146.70 and a beta of 1.03. The stock has a fifty day moving average price of $17.21 and a two-hundred day moving average price of $19.84. Mirion Technologies has a 12-month low of $14.11 and a 12-month high of $30.28.

Mirion Technologies (NYSE:MIR) last announced its quarterly earnings data on Tuesday, July 28th. The company reported $0.12 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.10 by $0.02. Mirion Technologies had a return on equity of 6.57% and a net margin of 2.39%.The business had revenue of $266.80 million for the quarter, compared to analysts’ expectations of $269.32 million. During the same period last year, the firm earned $0.11 earnings per share. The company’s revenue for the quarter was up 19.7% compared to the same quarter last year. Mirion Technologies has set its FY 2026 guidance at 0.480-0.550 EPS. As a group, sell-side analysts forecast that Mirion Technologies will post 0.53 EPS for the current fiscal year.

Insider Transactions at Mirion Technologies

In other news, CAO Christopher A. Moore sold 8,400 shares of the stock in a transaction that occurred on Thursday, May 7th. The stock was sold at an average price of $19.64, for a total transaction of $164,976.00. Following the completion of the transaction, the chief accounting officer directly owned 22,157 shares of the company’s stock, valued at approximately $435,163.48. This represents a 27.49% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. Insiders own 6.30% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently bought and sold shares of MIR. Stephens Investment Management Group LLC acquired a new position in shares of Mirion Technologies during the 4th quarter worth $18,969,000. Tredje AP fonden purchased a new position in shares of Mirion Technologies in the 4th quarter valued at about $6,576,000. UBS Group AG lifted its stake in shares of Mirion Technologies by 1.2% in the fourth quarter. UBS Group AG now owns 4,852,587 shares of the company’s stock valued at $113,648,000 after purchasing an additional 55,754 shares during the period. Allspring Global Investments Holdings LLC lifted its stake in shares of Mirion Technologies by 81.5% in the fourth quarter. Allspring Global Investments Holdings LLC now owns 1,030,230 shares of the company’s stock valued at $24,550,000 after purchasing an additional 462,643 shares during the period. Finally, First National Advisers LLC purchased a new stake in Mirion Technologies during the fourth quarter worth about $2,604,000. Institutional investors and hedge funds own 78.51% of the company’s stock.

Key Headlines Impacting Mirion Technologies

Here are the key news stories impacting Mirion Technologies this week:

• Positive Sentiment: Adjusted earnings beat estimates: Mirion reported Q2 adjusted EPS of $0.12, above the $0.10 consensus estimate and up from $0.11 a year earlier. Mirion Technologies Q2 earnings beat estimates
• Positive Sentiment: Strong revenue growth and expected second-half momentum: Revenue increased 19.7% year over year to $266.8 million. Management expects second-half organic growth of approximately 7.5%-11.2% and adjusted EBITDA margins of 27%-29%, supporting its expectations for continued operating improvement. Mirion maintains 2026 outlook
• Neutral Sentiment: Full-year guidance was maintained: Mirion reaffirmed FY 2026 EPS guidance of $0.48-$0.55 and revenue guidance of roughly $1.1 billion. The EPS range brackets the $0.53 analyst consensus, while revenue guidance is broadly in line with expectations. Mirion Q2 2026 earnings call summary
• Negative Sentiment: Quarterly revenue missed forecasts: Q2 sales of $266.8 million fell short of the $269.3 million consensus estimate. While the shortfall was modest, it may have disappointed investors given the stock’s elevated valuation and recent weakness. Mirion misses Q2 sales expectations

About Mirion Technologies

Mirion Technologies Inc (NYSE: MIR) is a leading global provider of radiation detection, measurement and monitoring solutions. The company’s portfolio includes instrumentation, software and service offerings designed to detect, quantify and manage radiation in nuclear power, oil and gas, defense and homeland security, medical imaging and diagnostic applications. Mirion’s product suite spans personal and environmental dosimetry, area monitors, digital imaging detectors and turnkey solutions for decommissioning and environmental remediation projects.

Mirion traces its origins to the combination of several established radiation measurement businesses, including the former Canberra nuclear instrumentation division, and has been supported by private equity investors before completing its initial public offering on the New York Stock Exchange in 2023.